DONATE MAINS

The Institute

The Institute

The Institut de la Vision is one of the most important research centers in Europe on eye diseases. Conceived as a place of gathering and exchanges, it brings together in a single building researchers, clinicians and industrial partners.

Read more

 

Menu-article-accordeon-the-institute


A Center for integrated research on eye diseases

Conceived as a place of gathering and exchanges, the Institut de la Vision enables the sharing of ideas and skills, the emergence of new questions and facilitates the delicate process of translating fundamental discoveries into new treatments.

The Institute's goal is to discover, test and develop treatments and technological innovations of tomorrow in order to prevent or limit visual impairment and to improve the autonomy and the quality of life of patients.

It harbors, aside from the research center, a clinical investigation center, a rare disease reference center and an incubator for innovative start-up. These activities are developed in the legal framework of the Foundation Voir & Entendre.

 


boite de petri et pipette 0 (1)

Research

The building of 6000 m2 houses more than 15 research teams (Inserm - UPMC - CNRS) working on different eyesight problems: retina imaging, AMD (Age-related macular degeneration), glaucoma, diabetic retinopathies, retinitis pigmentosa, etc. Teams from the Paris Observatory, the Pasteur Institute, the CHI Créteil, the Institut Langevin and the European Institute for Theoretical Neuroscience also take part in the project.

Alongside these teams, companies settled in the Institute develop research projects in the field of vision: drug discovery, imaging, surgery, new technologies, etc.

The latest developments in analyzing, exploring and imaging are available for researchers and industry partners, and are grouped together on about twelve technological platforms dedicated to: tissue and cell imaging by confocal microscopy, adaptive optics, full field optical coherence tomography, functional explorations, DNA-collection, transcriptome and proteome analysis, bioinformatics, behavioral tests, patch clamp study of ionic channels, two-photon imaging and utilization of optogenetic tools, preclinical studies on non human primate, development of animal models, genetic therapy approaches, pharmacological and light toxicity studies, high-throughput screening.

Researchers and industry partners also benefit from the functional evaluation platform in the Clinical Investigation Centre of the Quinze-Vingts Hospital (CIC).


Treatments

jf et tubes a essais

The scientists of the Institut de la Vision work hand in hand with the clinicians of the Clinical Investigation Centre (CIC) of the Quinze-Vingts hospital.

The CIC, opened in 2004 upon appoval by Inserm and the Directorate of Hospitalisation and Care Management, is the only Clinical Investigation Center dedicated exclusively to ophthalmology in France. It also shelters the Reference Centre for Genetic Retinal Dystrophies.

More than fifty studies (phases I to III clinical trials, physiological and physiopathological studies, etc.) are at present in progress on AMD, retinitis pigmentosa, diabetic retinopathies, retinal vein occlusions, artificial retina, glaucoma and high resolution imagery of the retina.

Scientists and clinicians also work in close association with partner hospitals: Rothschild Ophthalmological Foundation, AP-HP (Lariboisière, Pitié-Salpétrière hospital) and CHI Créteil in particular.


schema 2bisi internet


Key Numbers 

6000 15 260 20
Square meters dedicated to fundamental research More than 15 teams distributed in 4 departments Researchers Clinicians
12 1 50 8
Advanced technology platforms - Clinical Investigation Center dedicated to vision
- National Reference Centre for Rare Retinal Diseases
- Incubator for start-ups
- Institute Carnot « Voir & Entendre»
More than 50 ongoing clinical trials Hosted companies